S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
CGC   18.50 (-3.90%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
BAC   32.79 (-0.91%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
CGC   18.50 (-3.90%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
BAC   32.79 (-0.91%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
CGC   18.50 (-3.90%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
BAC   32.79 (-0.91%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
CGC   18.50 (-3.90%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
BAC   32.79 (-0.91%)
DIS   148.72 (+7.32%)
Log in

Irhythm Technologies Stock Price, Forecast & Analysis (NASDAQ:IRTC)

$63.04
-4.38 (-6.50 %)
(As of 11/13/2019 04:00 PM ET)
Today's Range
$56.24
Now: $63.04
$66.96
50-Day Range
$63.01
MA: $69.40
$79.42
52-Week Range
$56.24
Now: $63.04
$98.13
Volume2.38 million shs
Average Volume386,177 shs
Market Capitalization$1.57 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.72
iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRTC
CUSIPN/A
Phone415-632-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$147.29 million
Book Value$2.25 per share

Profitability

Net Income$-48,280,000.00

Miscellaneous

Employees748
Market Cap$1.57 billion
Next Earnings Date2/11/2020 (Estimated)
OptionableOptionable

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.


Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

What is Irhythm Technologies' stock symbol?

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

How were Irhythm Technologies' earnings last quarter?

Irhythm Technologies Inc (NASDAQ:IRTC) announced its quarterly earnings data on Tuesday, November, 5th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.40) by $0.34. The business earned $55.96 million during the quarter, compared to analyst estimates of $53.76 million. Irhythm Technologies had a negative net margin of 26.45% and a negative return on equity of 97.79%. The company's quarterly revenue was up 46.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.43) EPS. View Irhythm Technologies' Earnings History.

When is Irhythm Technologies' next earnings date?

Irhythm Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, February 11th 2020. View Earnings Estimates for Irhythm Technologies.

What price target have analysts set for IRTC?

9 equities research analysts have issued twelve-month target prices for Irhythm Technologies' shares. Their forecasts range from $75.00 to $125.00. On average, they anticipate Irhythm Technologies' stock price to reach $101.63 in the next year. This suggests a possible upside of 61.2% from the stock's current price. View Analyst Price Targets for Irhythm Technologies.

What is the consensus analysts' recommendation for Irhythm Technologies?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Irhythm Technologies.

Has Irhythm Technologies been receiving favorable news coverage?

News stories about IRTC stock have trended very negative recently, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Irhythm Technologies earned a news sentiment score of -3.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Irhythm Technologies.

Who are some of Irhythm Technologies' key competitors?

What other stocks do shareholders of Irhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include Twilio (TWLO), Tandem Diabetes Care (TNDM), Alibaba Group (BABA), DexCom (DXCM), NVIDIA (NVDA), Splunk (SPLK), Canopy Growth (CGC), Paycom Software (PAYC), Netflix (NFLX) and Paypal (PYPL).

Who are Irhythm Technologies' key executives?

Irhythm Technologies' management team includes the folowing people:
  • Mr. Kevin M. King, Pres, CEO & Director (Age 63)
  • Mr. Matthew C. Garrett, Chief Financial Officer (Age 51)
  • Mr. David A. Vort, Exec. VP of Sales (Age 53)
  • Dr. Derrick Sung, Exec. VP of Strategy & Corp. Devel. (Age 46)
  • Mr. Karim Karti, Chief Operating Officer (Age 50)

When did Irhythm Technologies IPO?

(IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Who are Irhythm Technologies' major shareholders?

Irhythm Technologies' stock is owned by many different of institutional and retail investors. Top institutional investors include TimesSquare Capital Management LLC (2.81%), Massachusetts Financial Services Co. MA (0.94%), Great Lakes Advisors LLC (0.29%), Rhumbline Advisers (0.21%), California Public Employees Retirement System (0.19%) and Shaker Investments LLC OH (0.12%). Company insiders that own Irhythm Technologies stock include Bruce G Bodaken, David A Vort, Derrick Sung, Kevin M King, Matthew C Garrett, Merz Cathleen Noel Bairey, Raymond W Scott and Vijay K Lathi. View Institutional Ownership Trends for Irhythm Technologies.

Which major investors are selling Irhythm Technologies stock?

IRTC stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Rhumbline Advisers, Great West Life Assurance Co. Can, Cerebellum GP LLC, CIBC Private Wealth Group LLC and Bailard Inc.. Company insiders that have sold Irhythm Technologies company stock in the last year include Bruce G Bodaken, David A Vort, Derrick Sung, Kevin M King, Matthew C Garrett and Merz Cathleen Noel Bairey. View Insider Buying and Selling for Irhythm Technologies.

Which major investors are buying Irhythm Technologies stock?

IRTC stock was bought by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Massachusetts Financial Services Co. MA, California Public Employees Retirement System, First Trust Advisors LP, BBVA USA Bancshares Inc., Shaker Investments LLC OH, Russell Investments Group Ltd. and Tower Research Capital LLC TRC . View Insider Buying and Selling for Irhythm Technologies.

How do I buy shares of Irhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Irhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $63.04.

How big of a company is Irhythm Technologies?

Irhythm Technologies has a market capitalization of $1.57 billion and generates $147.29 million in revenue each year. The company earns $-48,280,000.00 in net income (profit) each year or ($1.89) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe.View Additional Information About Irhythm Technologies.

What is Irhythm Technologies' official website?

The official website for Irhythm Technologies is http://www.irhythmtech.com/.

How can I contact Irhythm Technologies?

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]


MarketBeat Community Rating for Irhythm Technologies (NASDAQ IRTC)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  242 (Vote Outperform)
Underperform Votes:  201 (Vote Underperform)
Total Votes:  443
MarketBeat's community ratings are surveys of what our community members think about Irhythm Technologies and other stocks. Vote "Outperform" if you believe IRTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel